Page last updated: 2024-10-22

amitriptyline and Deficiency Diseases

amitriptyline has been researched along with Deficiency Diseases in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Deficiency Diseases: A condition produced by dietary or metabolic deficiency. The term includes all diseases caused by an insufficient supply of essential nutrients, i.e., protein (or amino acids), vitamins, and minerals. It also includes an inadequacy of calories. (From Dorland, 27th ed; Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rao, CK1

Other Studies

1 other study available for amitriptyline and Deficiency Diseases

ArticleYear
Combined therapy of E.C.T. and amitriptyline and L-tryptophan in the treatment of severe depression.
    The British journal of psychiatry : the journal of mental science, 1972, Volume: 120, Issue:554

    Topics: Amitriptyline; Deficiency Diseases; Depression; Electroconvulsive Therapy; Humans; Liver Function Te

1972